Several pharmaceutical manufacturers have announced the start of their outgoing shipments of influenza vaccines to healthcare providers and pharmacies in preparation for the 2025-2026 flu season, including GSK, CSL Seqirus, and Sanofi, according to a post by CIDRAP. Historically, every spring, a Food and Drug Administration (FDA) advisory committee meets to recommend which flu strains to include in the seasonal vaccine—recommendations that allow manufacturers to begin production. At the same time, the Centers for Disease …
Read More